News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Artimplant Postpones Year-End Report
January 31, 2013
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
The Board of Directors has decided to postpone the publication of Artimplant's Year-End Report until February 27, 2013. The original publication date was February 1, 2013.
Twitter
LinkedIn
Facebook
Email
Print
Europe
MORE ON THIS TOPIC
Business
US biotechs take lion’s share of $54.5B VC money raised since 2025
October 26, 2026
·
1 min read
·
Gabrielle Masson
Policy
Roche flags ‘final opportunity’ for Germany to reestablish as a reliable investment location
October 23, 2026
·
2 min read
·
Nick Paul Taylor
Manufacturing
Sanofi breaks ground on insulin plant after securing German government support
October 19, 2026
·
2 min read
·
Nick Paul Taylor
cancer
Merck/Moderna, Summit/Akeso and ADCs to headline ESMO 2026
October 19, 2026
·
8 min read
·
Tristan Manalac
